NUROSOFT : Press Release on the Annual General Meeting – 12/06/2023

Press release

Iraklio Attica, Monday, 12 June 2023

Annual General Meeting of Neurosoft S.A.

Iraklio Attica, Monday, 12 June 2023 - The Annual Ordinary Shareholders' General Meeting of Neurosoft, a fully integrated ICT Company, traded on Milan's Euronext Growth Italia market (GRS802003004, Reuters NRST.MI, Bloomberg NRST:IM), has Banca Ιnvestis as its Euronext Growth Adviser, was held today and was attended by four

1. shareholders who had deposited their shares, either in person or by proxy, representing 21.482.537 shares out of a total of 25,584,594 shares, i.e. 83,97 % of the paid-up share capital.

Financial Statements of Neurosoft Group as of December 31st , 2022

The shareholders approved the annual corporate and consolidated financial statements for financial year 2022, as well as the Board of Directors Report (Management Report) and the Auditor's Report for the same fiscal year 2022. The shareholders approved no dividend distribution and Company's FY 2022 net profit has been entirely allocated to retained earnings reserve.

The main 2022 consolidated results of Neurosoft Group are outlined below:

• Consolidated Revenues in 2022 amounted to € 23,01 million (€15,76 million in 2021)

• Gross Profit in 2022 amounted to €5,29 million (€3.52 million in 2021)

• EBITDA in 2022 amounted to € 2,89 million (€ 2.35 million in 2021)
• EBIT in 2022 amounted to € 1,58 million (€ 0.80 million in 2021)
• Net Profit in 2022 amounted to € 1.28 million (€ 0.90 million in 2021)
• Net Debt in 2022 amounted to € (2.88) million (€(0.45) million in 2021)
• Total equity structure verifies article 119 par. 4 of L. 4548/2018. The Company's main shareholder is committed to enhance Neurosoft capital structure in case of need

The FY 2022 ended with consolidated revenues equal to € 23,01 million continuing last year's upturn. Undoubtfully,

the use of new technologies changes the business models, provides new revenue opportunities and sets out the

most common strategic trend. Neurosoft is well positioned among domestic technology providers capable of

providing unique solutions to its clients and this is illustrated in the record high levels of this year.

2022 EBITDA (€2.89 million) proves a truly extraordinary year and it is the direct result of the continuous efforts and

commitment that the company has performed during the last few years in order to deliver value to stakeholders

and partners.

Economies of scale, cost control processes, expanded clientele basis and strategic alliance reflect the outstanding

financial performance.

2022 EBIT stands at € 1,58 million (€ 0.8 million in 2021-97.5%y-o-y increase) and, as a result, 2022 Net Profit is

equal to € 1.28 million (€ 0.90 million in 2021).

2022 Equity is equal to € 5.34 million (€ 4.06 million in 2021) with a 2022 Net Cash that amounts to € (2.88) million

versus net debt of € (0.45) million in 2021, proving company's strong liquidity levels.

Additionally, as of December 31, 2022 the Company has positive working capital of €4.23 Million, as well as, sufficient

undrawn borrowing facilities that can be utilized if needed. The Company's main shareholder is committed to

enhance its capital structure in case it is deemed necessary, for at least within the next 12 months from the approval

of Financial Statements.

Moreover, the Shareholders' Meeting passed the following resolutions according to the daily agenda briefly

described below:

• Approval of the overall management of the Company and discharge of the Statutory Auditors of the Company for the financial year 2022
  The Shareholders' Meeting discharged the Directors and the Auditors from any liability related to the results of fiscal year 2022, as well as the annual financial statements of the said fiscal year.
• Approval of the remuneration payable to the Board of Directors for fiscal year 2022, inncluding pre-approved remuneration for the first half of 2023, and pre-approval - determination of the remuneration payable for fiscal year 2023 and the first half of 2024.
  The shareholders approved the remuneration payable to the Board of Directors for financial year 2022 and for the first semester of 2023 and pre-approved the remuneration to be paid to the Board of Directors for the second semester of 2023, as well as for the first semester of 2024.
• Appointment of Statutory Auditors for the audit of financial statements (corporate and consolidated) for fiscal year 2023 and determination of their remuneration.
  The shareholders approved the appointment of the auditing firm "Pricewaterhouse Coopers SA" (PwC) as
  Certified Auditors for financial year 2023 (auditing of the financial statements, corporate and consolidated), approving their fees as well.

• Approval of distribution of financial statements for fiscal year 2022 and of non-distribution of dividend. Aproved the non-distributionof dividend for fiscal year 2022
• Approval - validation of contracts between the Company and its affiliates.
  No contracts have been signed by and between the Company and its affiliates in 2022.
• Other Announcements and approvals
  The Chairman of the General Meeting outlined the goals and prospects of this year and the new projects of the company.

The full text of the resolutions of the annual Ordinary General Meeting can be found on the company's website: www.neurosoft.gr

Neurosoft S.A., a Greek company listed on the Euronext Growth Milan market , organized and managed by the Italian Stock Exchange (ISIN GRS802003004, Reuters NRST.MI, Bloomberg NRST:IM), was founded in 1994 with the vision to provide superior products, innovative solutions and exclusive services to its international clients. Neurosoft is a fully integrated ICT company with Field Services, Systems Integration and Cyber Security capabilities. The staff headcount exceeds 200+ highly skilled employees with deep experience in their field. The company is based in Athens with presence in Cyprus.

Business areas covered by Neurosoft: Cyber Security Operations: Provision of high-end Cyber Security solutions and services and development of innovative security products. In a world of viruses, malwares, and hacktivists, Neurosoft has compiled a suite of practical and technologically advanced tools and methods to significantly enhance the protection of your mission-critical data. Infrastructure & Cloud Operations: Design, implementation, operation and support of large-scale ICT infrastructure solutions for Operators of Critical Networks and Critical National Infrastructure Stakeholders. Our vast experience in complex projects makes Neurosoft the ideal partner for any ICT infrastructure requirement. Field Services Operations: Neurosoft offers high-quality,on-site logistic and warehousing services with 200+ field service technicians, offering 40+ service points in Greece and Cyprus.

The company is committed to client impact, continuous investments in R&D, innovation, adoption of advanced methodologies and well-known international standards (ISO9001, ISO27001, ISO 14001, ISO 45001, ISO 22301). It demonstrates a track record of successful local & international group (multi-country) installations & continuous technical support, always on time - on budget - on spec.

As of today, Banca Investis is Neurosoft's Euronext Growth Advisor for the Euronext Growth Milan market.

Press release available on www.neurosoft.gr

For further information please contact:

INVESTOR RELATIONS

Neurosoft S.A. |[e-mail]| T: [phone]

EURONEXT GROWTH ADVISOR

Banca Investis| [e-mail]| T:[phone]